Skip to main content
Livermore
Livermore
ZHEN

Aurinia Pharmaceuticals Inc.

AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001600620

In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of AUPH: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1781171−6
Shares55.8M219.5K56.0M+480.6K (+0.9%)
Value$280.8M$1.10M$319.9M+$40.2M (+14.4%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to AUPH in Q2 2024
InstitutionSharesValue% of portfolio
Segall Bryant & Hamill, LLC553,744$3.16M0.06%
Stonepine Capital Management, LLC300,000$1.71M1.56%
AQR Capital Management LLC202,241$1.15M0.00%
PDT Partners, LLC171,349$978.4K0.09%
Virtus Investment Advisers, Inc.82,828$472.9K0.40%
Corebridge Financial, Inc.77,240$441.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.68,334$390.2K0.00%
Gotham Asset Management, LLC40,292$230.1K0.00%
J. Safra Sarasin Holding AG25,500$145.6K0.00%
Verition Fund Management LLC18,935$108.1K0.00%
Lazard Asset Management LLC18,866$107.0K0.00%
Creative Planning15,345$87.6K0.00%
National Asset Management, Inc.14,746$84.2K0.00%
Ameriprise Financial Inc10,685$61.0K0.00%
Virtus Fund Advisers, LLC6,788$38.8K0.15%
Caption Management, LLC6,076$34.7K0.00%
Activest Wealth Management3,000$17.1K0.01%
Optiver Holding B.V.1,785$10.2K0.00%
Lindbrook Capital, LLC1,190$6.79K0.00%
Jones Financial Companies LLLP700$4.00K0.00%
CVA Family Office, LLC194$1.11K0.00%
Signaturefd, LLC179$1.02K0.00%
The PNC Financial Services Group, Inc.162$9250.00%
Rothschild Investment LLC75$4280.00%
TD Waterhouse Canada Inc.20$1100.00%

Sold out (31)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of AUPH in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Level Four Advisory Services, LLC236,800$2.13M
Group One Trading, L.P.377,322$1.89M
Balyasny Asset Management LLC288,875$1.45M
Qube Research & Technologies Ltd172,153$862.5K
Superstring Capital Management LP98,691$494.4K
Hennion & Walsh Asset Management, Inc.75,787$379.7K
American International Group, Inc.66,738$334.4K
Cantor Fitzgerald, L. P.54,033$270.7K
Natixis50,717$254.1K
Flputnam Investment Management Co40,391$202.4K
Capstone Investment Advisors, LLC31,458$157.6K
Atom Investors LP30,658$153.6K
XTX Topco Ltd23,491$117.7K
Sherbrooke Park Advisers LLC23,017$115.3K
Quantbot Technologies LP20,500$102.7K
Dynamic Technology Lab Private Ltd17,444$87.0K
Tudor Investment Corp Et Al14,954$74.9K
Coastal Investment Advisors, Inc.13,738$68.8K
Commonwealth Equity Services, LLC11,307$57.0K
Great Valley Advisor Group, Inc.10,400$52.1K
Bridgefront Capital, LLC10,279$51.5K
Metropolitan Life Insurance Co7,999$40.1K
DekaBank Deutsche Girozentrale7,480$36.0K
Belvedere Trading LLC4,497$22.5K
ADAR1 Capital Management, LLC2,000$10.0K
Walleye Capital LLC1,279$6.41K
Resources Management Corp1,000$5.00K
Pacifica Partners Inc.1,000$4.99K
Truvestments Capital LLC687$3.44K
Lowe Wealth Advisors, LLC531$2.66K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC26$130

Not filed for Q2 2024 yet (1)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AUPH in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG219,468$1.10M